Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Presentation    source : Renovorx.com    save search

RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
Published: 2024-04-17 (Crawled : 23:00) - renovorx.com
RNXT | $1.26 5.0% 4.76% 3.5K twitter stocktwits trandingview |
| Email alert Add to watchlist

presentation meeting
RenovoRx Announces Late-Breaking Oral Presentation at 2023 ESMO World Congress on Gastrointestinal Cancer
Published: 2023-05-26 (Crawled : 04:20) - renovorx.com
RNXT | $1.26 5.0% 4.76% 3.5K twitter stocktwits trandingview |
| | O: -2.63% H: 4.86% C: 2.7%

presentation cancer gastrointestinal
RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology (CIO) Highlighting its Innovative Therapy Platform for Targeted Treatment of Pancreatic Cancer
Published: 2022-09-28 (Crawled : 13:00) - renovorx.com
RNXT | $1.26 5.0% 4.76% 3.5K twitter stocktwits trandingview |
| | O: 0.54% H: 12.9% C: 7.53%

treatment symposium presentation therapy cancer platform pancreatic
RenovoRx Announces Presentation at the 2022 SPECTRUM Conference Highlighting its Innovative RenovoTAMP™ Therapy for Targeted Treatment of Cancer
Published: 2022-01-19 (Crawled : 12:30) - renovorx.com
RNXT | $1.26 5.0% 4.76% 3.5K twitter stocktwits trandingview |
| | O: -0.49% H: 1.47% C: -2.93%

treatment conference presentation therapy cancer
RenovoRx Announces Presentation at the 2022 SPECTRUM Conference Highlighting its Innovative RenovoTAMP™ Therapy for Targeted Treatment of Cancer
Published: 2022-01-18 (Crawled : 11:00) - renovorx.com
RNXT | $1.26 5.0% 4.76% 3.5K twitter stocktwits trandingview |
| | O: -1.72% H: 5.01% C: 2.76%

treatment conference presentation therapy cancer
Presentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy as a Potential Innovative Treatment for Pancreatic Cancer
Published: 2021-11-09 (Crawled : 12:26) - renovorx.com
RNXT | $1.26 5.0% 4.76% 3.5K twitter stocktwits trandingview |
| | O: 67.28% H: 38.23% C: -9.83%

presentation treatment potential therapy cancer pancreatic pancreas
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.